Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
124,590,769
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
5,053,799
-
Shares change
-
+5,053,799
-
Total reported value, excl. options
-
$50,841,000
-
Value change
-
+$50,841,009
-
Number of buys
-
21
-
Price
-
$10.05
Institutional Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (DFPH) as of Q2 2020
As of 30 Jun 2020 Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (DFPH) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,053,799 shares of stock of the company.
Largest 10 holders included UBS OCONNOR LLC, DEUTSCHE BANK AG\, HBK INVESTMENTS L P, FIR TREE CAPITAL MANAGEMENT LP, MOORE CAPITAL MANAGEMENT, LP, Radcliffe Capital Management, L.P., Hudson Bay Capital Management LP, PICTON MAHONEY ASSET MANAGEMENT, Owl Creek Asset Management, L.P., and Jefferies Group LLC.
This table shows 23 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.